Exploring allelic imbalance within paraffin-embedded tumor biopsies using pyrosequencing technology

被引:6
作者
Hidalgo Pascual, Manuel
Royo, Jose Luis
Jose Martinez-Tello, Francisco
Crespo, Carmen
Salinas, Ana
Ferrero Herrero, Eduardo
Lopez-Garcia, Maria
Miguel Real, Luis
Ruiz, Agustin
Ramirez-Lorca, Reposo
机构
[1] Neocodex SL, Dept Genom Estruct, Seville 41092, Spain
[2] Hosp Univ Octubre 12, Serv Cirugia Gen B, Madrid, Spain
[3] Hosp Univ 12 Octubre, Dept Anat Patol, Madrid, Spain
[4] Hosp Ramon & Cajal, Med Oncol Serv, E-28034 Madrid, Spain
关键词
11q13; allelic imbalance; EMSY; PAK1; pyrosequencing;
D O I
10.1515/CCLM.2006.198
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The comparison of molecular genetic changes in healthy and pathological tissues has historically led to the identification of oncogenes and tumor suppressor genes. It is very common that studies investigating loss of heterozygosity are carried out retrospectively on paraffin-embedded samples. Methods: In this study, we evaluated the power of pyrosequencing for determining the loss of heterozygotic regions. The present method uses the fact that pyrosequencing is an accurate, sensitive and reproducible technique. The method is also simple to perform, with results available in 96-well format, making the assays amenable to automation. Thus, we analyzed nine single nucleotide polymorphisms along 1 Mb between the EMSY and PAK1 genes on 11q13, a region frequently rearranged in different tumors and cell lines. We assessed the study using samples from breast cancer and thyroid cancer biopsies. Results and conclusions: We conclude that this technique is capable of detecting variations of > 10% in allele loss. However, strong allele imbalances were detected, depending on the origin of the sample. Seven out of the nine markers used exhibited differential allele amplification, depending on the DNA quality (p < 0.01).
引用
收藏
页码:1076 / 1081
页数:6
相关论文
共 21 条
[1]   Single-nucleotide polymorphism analysis by pyrosequencing [J].
Ahmadian, A ;
Gharizadeh, B ;
Gustafsson, AC ;
Sterky, F ;
Nyrén, P ;
Uhlén, M ;
Lundeberg, J .
ANALYTICAL BIOCHEMISTRY, 2000, 280 (01) :103-110
[2]   Analysis of the p53 tumor suppressor gene by pyrosequencing [J].
Ahmadian, A ;
Lundeberg, J ;
Nyrén, P ;
Uhlén, M ;
Ronaghi, M .
BIOTECHNIQUES, 2000, 28 (01) :140-+
[3]  
[Anonymous], 2002, GENETIC BASIS HUMAN
[4]   Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma [J].
Bekri, S ;
Adélaïde, J ;
Merscher, S ;
Grosgeorge, J ;
Caroli-Bosc, F ;
Perucca-Lostanlen, D ;
Kelley, PM ;
Pébusque, MJ ;
Theillet, C ;
Birnbaum, D ;
Gaudray, P .
CYTOGENETICS AND CELL GENETICS, 1997, 79 (1-2) :125-131
[5]   Mutation detection by pyrosequencing:: sequencing of exons 5-8 of the p53 tumor suppressor gene [J].
Garcia, CA ;
Ahmadian, A ;
Gharizadeh, B ;
Lundeberg, J ;
Ronaghi, M ;
Nyrén, P .
GENE, 2000, 253 (02) :249-257
[6]   EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer [J].
Hughes-Davies, L ;
Huntsman, D ;
Ruas, M ;
Fuks, F ;
Bye, J ;
Chin, SF ;
Milner, J ;
Brown, LA ;
Hsu, F ;
Gilks, B ;
Nielsen, T ;
Schulzer, M ;
Chia, S ;
Ragaz, J ;
Cahn, A ;
Linger, L ;
Ozdag, H ;
Cattaneo, E ;
Jordanova, ES ;
Schuuring, E ;
Yu, DS ;
Venkitaraman, A ;
Ponder, B ;
Doherty, A ;
Aparicio, S ;
Bentley, D ;
Theillet, C ;
Ponting, CP ;
Caldas, C ;
Kouzarides, T .
CELL, 2003, 115 (05) :523-535
[7]   COMPARATIVE GENOMIC HYBRIDIZATION FOR MOLECULAR CYTOGENETIC ANALYSIS OF SOLID TUMORS [J].
KALLIONIEMI, A ;
KALLIONIEMI, OP ;
SUDAR, D ;
RUTOVITZ, D ;
GRAY, JW ;
WALDMAN, F ;
PINKEL, D .
SCIENCE, 1992, 258 (5083) :818-821
[8]   Large-scale genotyping of complex DNA [J].
Kennedy, GC ;
Matsuzaki, H ;
Dong, SL ;
Liu, WM ;
Huang, J ;
Liu, GY ;
Xu, X ;
Cao, MQ ;
Chen, WW ;
Zhang, J ;
Liu, WW ;
Yang, G ;
Di, XJ ;
Ryder, T ;
He, ZJ ;
Surti, U ;
Phillips, MS ;
Boyce-Jacino, MT ;
Fodor, SPA ;
Jones, KW .
NATURE BIOTECHNOLOGY, 2003, 21 (10) :1233-1237
[9]   A novel BRCA2-binding protein and breast and ovarian tumorigenesis [J].
King, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1252-1253
[10]   CCR5 expression influences the progression of human breast cancer in a p53-dependent manner [J].
Mañes, S ;
Mira, E ;
Colomer, R ;
Montero, S ;
Real, LM ;
Gómez-Moutón, C ;
Jiménez-Baranda, S ;
Garzón, A ;
Lacalle, RA ;
Harshman, K ;
Ruíz, A ;
Martínez, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (09) :1381-1389